Preeminence of Dietary Supplements and Nutraceuticals

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
105
Preeminence of Dietary Supplements and Nutraceuticals Applications Prevails; Pharmaceutical Follows the Suit

Rockville, MD, June 27, 2018 (GLOBE NEWSWIRE) -- As a part of the amino acid family, use of L-hydroxyphenylalanine as an energy providing aromatic ingredient has significantly fuelled its demand across the dietary supplement and nutraceuticals space. This factor continues to remain instrumental in driving the growth of the L-hydroxyphenylalanine market during the period of forecast. Moreover, various pharmaceutical uses of L-hydroxyphenylalanine including its application in formulations to treat Parkinson’s disease, Alzheimer’s disease and cancer are also expected to contribute to the overall growth of the L-hydroxyphenylalanine market. Being recognized as GRAS (Generally Recognized as Safe) by the FDA, the use of L-hydroxyphenylalanine in food and beverage sector has also witnessed significant growth in recent times.

Request For Sample Report- https://www.factmr.com/connectus/sample?flag=...rep_id=918

A new research study by Fact.MR reveals growth pathways for L-hydroxyphenylalanine from a global viewpoint during the period of forecast, 2018-2028. The report includes estimations that reflect global sales of L-hydroxyphenylalanine which are expected to cross US$ 1,500 Mn by end of the year of assessment (2028). The sales of L-hydroxyphenylalanine are expected to remain concentrated in the developed countries of North America and emerging economies in the Asia Pacific excluding Japan (APEJ) region, given the increasing demand for L-hydroxyphenylalanine in anti-ageing creams and as effective adjuvant in cancer treatment in these regions.

L-Hydroxyphenylalanine Market: Use of L-Hydroxyphenylalanine in Dietary Supplements to Spearhead in the Coming Years

Dietary supplements and nutraceuticals have witnessed significant proliferation across various countries worldwide, given the increasing consumer awareness regarding healthy diet and exercise. Moreover, the growing number of individuals participating in heavy physical activities has further complemented the use of supplements for enhancing muscle growth. Being an amino acid, L-hydroxyphenylalanine as an energy ingredient has witnessed high demand in the production of health supplements, which is expected to fuel the growth of the L-hydroxyphenylalanine market during the period of forecast.

L-Hydroxyphenylalanine Market: High Prevalence of Parkinson’s Disease to Call for Efficient Treatment Solutions

Parkinson’s disease is directly associated with low blood pressure and orthostatic hypotension, that translates into need for effective pharmaceutical formulations that facilitate high energy flow and increase the heart rate. That said, L-hydroxyphenylalanine plays an imperative role in producing significant amount of energy that improves parkinsonian orthostatic hypotension and raises blood pressure, causing the shaking of body to reduce drastically. This factor coupled with increasing cases of Parkinson’s disease across the globe has enhanced the demand of L-hydroxyphenylalanine, in turn contributing to the growth of the L-hydroxyphenylalanine market during the period of forecast.

To know more about L-Hydroxyphenylalanine Market Trends, Check the link - https://www.factmr.com/report/918/l-hydroxyph...ine-market

L-Hydroxyphenylalanine Market: Melanoma Treatment to Create Potential Avenues

Treatment of melanoma is expected to pave significant pathways for growth of the L-h market, as studies reveal the potential of the L-h in production of melanin. The Federation of American Societies for Experimental Biology Journal has highlighted the link between mitochondrial function and production of melanin in cancerous skin cells. Post examination revealed that the rate of Reactive Oxygen Species generation in darker cells were high as compared to medium and low level pigments. Provision of L-h as a building block for melanin production, has been used to activate medium and light cells to increase the production of melanin. This concept is expected to trigger coupling cellular adaptation and stress signaling through ROS signaling, which in turn has the potential to support development of anti-cancer drugs for treating melanoma. This approach is expected provide substantial growth opportunities for the use L-h, consequently fuelling the growth of the L-h market during the forecast period.

Buy this Report - https://www.factmr.com/checkout/918/S

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Mr. Rohit Bhisey Fact.MR 11140 Rockville Pike Suite 400 Rockville, MD 20852 United States Email: sales@factmr.com Web: https://www.factmr.com/ Follow us on Linkedin: https://www.linkedin.com/company/factmr/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Revolutionizing Employee Benefits with Universal Care Groups

Updated Category News Views 247

Universal Care Groups LLC Introduces Innovative Healthcare Solutions Universal Care Groups LLC (“UCG”) is making significant strides in the healthcare sector with its introduction of a cutting-edge platinum Section 125 Cafeteria plan and Minimum Essential Coverage (MEC) options designed specifically for employers and employees. This innovative approach is set to...

Continue Reading
Rezolute Inc. Reveals Financial Outcomes and Business Insights

Updated Category News Views 115

Rezolute Inc. Financial Results Overview Rezolute, Inc. (NASDAQ: RZLT) is making significant strides in the biopharmaceutical industry, particularly focusing on treating hypoglycemia resulting from hyperinsulinism. In a recent financial report, Rezolute presented its outcomes for the fourth quarter and the full fiscal year trailing off June 30, 2025. Key Business...

Continue Reading
Elite Longevity Program Offers Immortality Insights for $1 Million

Updated Category News Views 223

Exploring the Latest in Longevity Science Renowned tech entrepreneur Bryan Johnson is capturing attention with his ambitious approach to anti-aging. His latest endeavor, a premium health program, aims to provide unparalleled longevity insights to just three individuals willing to invest $1 million per year. It’s a groundbreaking facility engineered from years of...

Continue Reading
Star Refrigeration: Key Insights at Cold Chain Live 2025

Updated Category News Views 185

Star Refrigeration Takes the Stage at Cold Chain Live 2025 Star Refrigeration is poised to make a significant impact at Cold Chain Live 2025 as a Platinum Sponsor. This prestigious event gathers industry leaders, operators, and innovators working within the temperature-controlled logistics sector, taking place at the Telford International Centre. Insightful Presentations...

Continue Reading
Max Stock Limited Reveals New Employment for Eliad Max

Updated Category News Views 192

Max Stock Limited Discloses Eliad Max's Employment Max Stock Limited (TASE: MAXO) has made an important announcement regarding the employment of Mr. Eliad Max, son of company's CEO, Mr. Ori Max. This decision was disclosed following approvals from the remuneration committee and the board of directors. Details of the Employment Agreement On two separate occasions, the...

Continue Reading